Anzeige
Mehr »
Lynx Broker
Login
Dienstag, 15.10.2019 Börsentäglich über 12.000 News von 613 internationalen Medien
Mega-Chance im Tech-Sektor +++ Konkurrenz tief beeindruckt +++ Aktie noch günstig
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0NBNG ISIN: US0231112063 Ticker-Symbol: EH3A 
Tradegate
15.10.19
14:22 Uhr
14,000 Euro
0,000
0,00 %
Branche
Pharma
Aktienmarkt
NASDAQ Biotech
1-Jahres-Chart
AMARIN CORPORATION PLC ADR Chart 1 Jahr
5-Tage-Chart
AMARIN CORPORATION PLC ADR 5-Tage-Chart
RealtimeGeldBriefZeit
13,900
14,100
15:56
14,000
14,100
15:56

Aktuelle News zur AMARIN Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
14:22Goldman neutral on Amarin in premarket analyst action4
MoAmarin's November Rendezvous With A Stepmotherly FDA, And Other Headlines: The Good, Bad, And Ugly Of Biopharma18
FrJon Najarian Sees Unusual Options Activity In SmileDirectClub, Amarin17
AMARIN Aktien ab 5,00 US-Dollar handeln - Ohne versteckte Kosten!
FrAcasti Pharma And Amarin In Severe Hypertriglyceridemia22
Mi5 Top Stock Trades for Thursday: IRBT, AMRN, Canopy Growth31
03.10.Amarin Corporation (AMRN) Investor Presentation - Slideshow33
23.09.Amarin Corporation plc: Amarin to Participate in the Cantor Global Healthcare Conference17
20.09.Amarin: A Favorable Trade Heading Into AdComm And SNDA27
16.09.Amarin Corporation plc: National Lipid Association's New Position Statement on Use of Icosapent Ethyl in High ...32
12.09.AMARIN CORP PLC - 8-K, Current Report13
11.09.November Ad Com date confirmed for CV benefit claim for Amarin's Vascepa25
11.09.Why Amarin Stock Dropped 19% in August25
10.09.Amarin Corporation (AMRN) Investor Presentation - Slideshow12
09.09.Amarin Corporation plc (AMRN) CEO John Thero Presents at H.C. Wainwright 21st Annual Global Investment Conference (Transcript)12
09.09.Amarin: Keep Your Dry Powder Ready17
03.09.Amarin Corporation plc: New 2019 Updates to the European Society of Cardiology's and European Atherosclerosis Society's Guidelines for the Management of Dyslipidaemias Incorporate Findings from the REDUCE-IT Cardiovascular Outcomes Study1.265Clinical Practice Guidelines address how best to prevent cardiovascular events in high-risk patients with elevated triglycerides on statin treatment, among millions of people globallyBEDMINSTER, N.J....
► Artikel lesen
28.08.Amarin Corporation plc: Amarin to Participate in the H.C. Wainwright 21st Annual Global Investment Conference10
27.08.Amarin up 1% premarket on continued market acceptance of Vascepa and REDUCE-IT data18
27.08.Amarin Corporation plc: Amarin Provides Overview on Growing Global Attention on REDUCE-IT Results and Cardiovascular ...11
21.08.Amarin continues rebound, up 3%20
Seite:  Weiter >>
159 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,3